• Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 26 Nov 2024 03:39:10   America/Chicago


    Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat November 26, 2024 Share Link copied to clipboard. Shares of Amicus Therapeutics, Inc.
    Read more...
Share on,